These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 19748118)

  • 1. NPY regulation of bone remodelling.
    Lee NJ; Herzog H
    Neuropeptides; 2009 Dec; 43(6):457-63. PubMed ID: 19748118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothalamic control of bone formation: distinct actions of leptin and y2 receptor pathways.
    Baldock PA; Sainsbury A; Allison S; Lin EJ; Couzens M; Boey D; Enriquez R; During M; Herzog H; Gardiner EM
    J Bone Miner Res; 2005 Oct; 20(10):1851-7. PubMed ID: 16160743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NPY and Y receptors: lessons from transgenic and knockout models.
    Lin S; Boey D; Herzog H
    Neuropeptides; 2004 Aug; 38(4):189-200. PubMed ID: 15337371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NPY revealed as a critical modulator of osteoblast function in vitro: new insights into the role of Y1 and Y2 receptors.
    Teixeira L; Sousa DM; Nunes AF; Sousa MM; Herzog H; Lamghari M
    J Cell Biochem; 2009 Aug; 107(5):908-16. PubMed ID: 19459152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central and peripheral mechanisms of the NPY system in the regulation of bone and adipose tissue.
    Shi YC; Baldock PA
    Bone; 2012 Feb; 50(2):430-6. PubMed ID: 22008645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical interplay between neuropeptide Y and sex steroid pathways in bone and adipose tissue homeostasis.
    Allison SJ; Baldock PA; Enriquez RF; Lin E; During M; Gardiner EM; Eisman JA; Sainsbury A; Herzog H
    J Bone Miner Res; 2009 Feb; 24(2):294-304. PubMed ID: 18847327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide Y and its receptor subtypes specifically modulate rat peritoneal macrophage functions in vitro: counter regulation through Y1 and Y2/5 receptors.
    Dimitrijević M; Stanojević S; Vujić V; Beck-Sickinger A; von Hörsten S
    Regul Pept; 2005 Jan; 124(1-3):163-72. PubMed ID: 15544855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of NPY Y1 receptor-mediated pathways: assessment using NPY Y1 receptor knockouts.
    Pedrazzini T
    Neuropeptides; 2004 Aug; 38(4):267-75. PubMed ID: 15337379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothalamic regulation of cortical bone mass: opposing activity of Y2 receptor and leptin pathways.
    Baldock PA; Allison S; McDonald MM; Sainsbury A; Enriquez RF; Little DG; Eisman JA; Gardiner EM; Herzog H
    J Bone Miner Res; 2006 Oct; 21(10):1600-7. PubMed ID: 16995815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential actions of NPY on seizure modulation via Y1 and Y2 receptors: evidence from receptor knockout mice.
    Lin EJ; Young D; Baer K; Herzog H; During MJ
    Epilepsia; 2006 Apr; 47(4):773-80. PubMed ID: 16650144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction to the reviews on neuropeptide Y.
    Gehlert DR
    Neuropeptides; 2004 Aug; 38(4):135-40. PubMed ID: 15337366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of NPY and Y2 receptors in epileptic brain tissue: an endogenous neuroprotective mechanism in temporal lobe epilepsy?
    Vezzani A; Sperk G
    Neuropeptides; 2004 Aug; 38(4):245-52. PubMed ID: 15337376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of neuropeptide Y receptors for the treatment of obesity.
    Sato N; Ogino Y; Mashiko S; Ando M
    Expert Opin Ther Pat; 2009 Oct; 19(10):1401-15. PubMed ID: 19743896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y and osteoblast differentiation--the balance between the neuro-osteogenic network and local control.
    Franquinho F; Liz MA; Nunes AF; Neto E; Lamghari M; Sousa MM
    FEBS J; 2010 Sep; 277(18):3664-74. PubMed ID: 20681986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors.
    Henry M; Ghibaudi L; Gao J; Hwa JJ
    Obes Res; 2005 Jan; 13(1):36-47. PubMed ID: 15761161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neuropeptide Y system: pathophysiological and therapeutic implications in obesity and cancer.
    Zhang L; Bijker MS; Herzog H
    Pharmacol Ther; 2011 Jul; 131(1):91-113. PubMed ID: 21439311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y and seizures: effects of exogenously applied ligands.
    Woldbye DP; Kokaia M
    Neuropeptides; 2004 Aug; 38(4):253-60. PubMed ID: 15337377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel role of Y1 receptors in the coordinated regulation of bone and energy homeostasis.
    Baldock PA; Allison SJ; Lundberg P; Lee NJ; Slack K; Lin EJ; Enriquez RF; McDonald MM; Zhang L; During MJ; Little DG; Eisman JA; Gardiner EM; Yulyaningsih E; Lin S; Sainsbury A; Herzog H
    J Biol Chem; 2007 Jun; 282(26):19092-102. PubMed ID: 17491016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of NPY receptors in the hypothalamus.
    Fetissov SO; Kopp J; Hökfelt T
    Neuropeptides; 2004 Aug; 38(4):175-88. PubMed ID: 15337370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complex plastic changes in the neuropeptide Y system during ethanol intoxication and withdrawal in the rat brain.
    Olling JD; Ulrichsen J; Christensen DZ; Woldbye DP
    J Neurosci Res; 2009 Aug; 87(10):2386-97. PubMed ID: 19267419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.